Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Physician–pharmacist collaborative practice and telehealth may transform hypertension management

Abstract

Community pharmacists play a crucial role in hypertension management and their intervention, mainly including education, medication monitoring, and reviewing, blood pressure (BP) measurement and cardiovascular risk factors tracking, have proved to enhance BP control and adherence to antihypertensive treatment. A multidisciplinary collaborative approach with the referring physician and a patient-centered model of care have been proved to be particularly effective for improving control of hypertension and promoting patients’ health. The inclusion of telehealth in such model (the so-called telepharmacy) may expand the reach of the pharmacist’s intervention and provide pharmacy operations and patient care at a distance with further benefits for hypertensive patients and their managing physicians. Very few randomized controlled studies have evaluated the clinical efficacy of the implementation of telepharmacy services in the management of hypertension, with the strongest evidence limited to physician–pharmacist collaborative interventions based on home BP telemonitoring plus patient education on lifestyle, drug therapy, and cardiovascular risk factors control. The results of these trials documented a benefit of telehealth mainly in terms of improvement of BP control consequent to antihypertensive medication intensification and optimization. Although promising, these results need to be corroborated through larger, prospective, and long-term studies, which should also evaluate additional long-term benefits of telepharmacy services in hypertension management.

Your institute does not have access to this article

Relevant articles

Open Access articles citing this article.

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. Di Palo KE, Kish T. The role of the pharmacist in hypertension management. Curr Opin Cardiol. 2018;33:382–7.

    PubMed  Article  Google Scholar 

  2. Proia KK, Thota AB, Njie GJ, Finnie RK, Hopkins DP, Mukhtar Q, et al. Community Preventive Services Task Force. Team-based care and improved blood pressure control: a community guide systematic review. Am J Prev Med. 2014;47:86–99.

    PubMed  PubMed Central  Article  Google Scholar 

  3. Carter BL, Rogers M, Daly J, Zheng S, James PA. The potency of team-based care interventions for hypertension: a meta-analysis. Arch Intern Med. 2009;169:1748–55.

    PubMed  PubMed Central  Google Scholar 

  4. Omboni S, Sala E. The pharmacist and the management of arterial hypertension: the role of blood pressure monitoring and telemonitoring. Expert Rev Cardiovasc Ther. 2015;13:209–21.

    CAS  PubMed  Article  Google Scholar 

  5. World Health Organization (WHO). Pharmacy-based hypertension management model: protocol and guidelines. A joint CINDI/EuroPharm Forum Project. 2005. Available at http://apps.who.int/iris/bitstream/10665/107638/1/E85730.pdf (last accessed 3 October2018).

  6. Albasri A, Prinjha S, McManus RJ, Sheppard JP. Hypertension referrals from community pharmacy to general practice: multivariate logistic regression analysis of 131 419 patients. Br J Gen Pract. 2018;68:e541–e550.

    PubMed  PubMed Central  Article  Google Scholar 

  7. O’Brien E, Atkins N, Stergiou G, Karpettas N, Parati G, Asmar R, et al. Working Group on Blood Pressure Monitoring of the European Society of Hypertension. European Society of Hypertension International Protocol revision 2010 for the validation of blood pressure measuring devices in adults. Blood Press Monit. 2010;15:23–38.

    Article  PubMed  Google Scholar 

  8. Non-invasive sphygmomanometers - Part 2: Clinical investigation of automated measurement type. American National Standards. ANSI/AAMI/ISO 81060-2:2013. Available at http://my.aami.org/aamiresources/previewfiles/8106002_1306_preview.pdf (last accessed 3 October 2018).

  9. Erdem DG, Erdem E, Dilek M, Aydogdu T, Selim N, Demiray F, et al. Accuracy of sphygmomanometers at pharmacies. Kidney Blood Press Res. 2009;32:231–4.

    PubMed  Article  Google Scholar 

  10. Gonzalvo J, Zillich A. Accuracy of automated community pharmacy-based blood pressure devices. J Am Pharm Assoc. 2003;2011:408–11.

    Google Scholar 

  11. Ross KL, Bhasin S, Wilson MP, Stewart SA, Wilson TW. Accuracy of drug store blood pressure monitors: an observational study. Blood Press Monit. 2013;18:339–41.

    PubMed  Article  Google Scholar 

  12. Hodgkinson J, Koshiaris C, Martin U, Mant J, Heneghan C, Hobbs FR, et al. Accuracy of monitors used for blood pressure checks in English retail pharmacies: a cross-sectional observational study. Br J Gen Pract. 2016;66:e309–314.

    PubMed  PubMed Central  Article  Google Scholar 

  13. Sabater-Hernández D, de la Sierra A, Sánchez-Villegas P, Baena MI, Amariles P, Faus MJ, MEPAFAR study workgroup. Magnitude of the white-coat effect in the community pharmacy setting: the MEPAFAR study. Am J Hypertens. 2011;24:887–92.

    PubMed  Article  Google Scholar 

  14. Sabater-Hernández D, De La Sierra A, Sánchez-Villegas P, Santana-Pérez FM, Merino-Barber L, Faus MJ, MEPAFAR Study Workgroup. Agreement between community pharmacy and ambulatory and home blood pressure measurement methods to assess the effectiveness of antihypertensive treatment: the MEPAFAR study. J Clin Hypertens (Greenwich). 2012;14:236–44.

    Article  Google Scholar 

  15. Sendra-Lillo J, Sabater-Hernández D, Sendra-Ortolá Á, Martínez-Martínez F. Agreement between community pharmacy, physician’s office, and home blood pressure measurement methods: the PALMERA Study. Am J Hypertens. 2012;25:290–6.

    PubMed  Article  Google Scholar 

  16. Albasri A, OʼSullivan JW, Roberts NW, Prinjha S, McManus RJ, Sheppard JP. A comparison of blood pressure in community pharmacies with ambulatory, home and general practitioner office readings: systematic review and meta-analysis. J Hypertens. 2017;35:1919–28.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  17. Machado M, Bajcar J, Guzzo GC, Einarson TR. Sensitivity of patient outcomes to pharmacist interventions. Part II: systematic review and meta-analysis in hypertension management. Ann Pharmacother. 2007;41:1770–81.

    PubMed  Article  Google Scholar 

  18. Morgado MP, Morgado SR, Mendes LC, Pereira LJ, Castelo-Branco M. Pharmacist interventions to enhance blood pressure control and adherence to antihypertensive therapy: Review and meta-analysis. Am J Health Syst Pharm. 2011;68:241–53.

    PubMed  Article  Google Scholar 

  19. Santschi V, Chiolero A, Colosimo AL, Platt RW, Taffé P, Burnier M, et al. Improving blood pressure control through pharmacist interventions: a meta-analysis of randomized controlled trials. J Am Heart Assoc. 2014;3:e000718.

    PubMed  PubMed Central  Article  Google Scholar 

  20. Cheema E, Sutcliffe P, Singer DR. The impact of interventions by pharmacists in community pharmacies on control of hypertension: a systematic review and meta-analysis of randomized controlled trials. Br J Clin Pharmacol. 2014;78:1238–47.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  21. Rotta I, Souza TT, Salgado TM, Correr CJ, Fernandez-Llimos F. Characterization of published randomized controlled trials assessing clinical pharmacy services around the world. Res Soc Adm Pharm. 2017;13:201–8.

    Article  Google Scholar 

  22. Kennelty KA, Polgreen LA, Carter BL. Team-based care with pharmacists to improve blood pressure: a review of recent literature. Curr Hypertens Rep. 2018;20:1.

    PubMed  PubMed Central  Article  Google Scholar 

  23. Kulchaitanaroaj P, Brooks JM, Chaiyakunapruk N, Goedken AM, Chrischilles EA, Carter BL. Cost-utility analysis of physician-pharmacist collaborative intervention for treating hypertension compared with usual care. J Hypertens. 2017;35:178–87.

    CAS  PubMed  Article  Google Scholar 

  24. Schell SF, Luke DA, Schooley MW, Elliott MB, Herbers SH, Mueller NB, et al. Public health program capacity for sustainability: a new framework. Implement Sci. 2013;8:15.

    PubMed  PubMed Central  Article  Google Scholar 

  25. Dunn SP, Birtcher KK, Beavers CJ, Baker WL, Brouse SD, Page RL 2nd, et al. The role of the clinical pharmacist in the care of patients with cardiovascular disease. J Am Coll Cardiol. 2015;66:2129–39.

    PubMed  Article  Google Scholar 

  26. Al Hamarneh YN, Houle SK, Padwal R, Tsuyuki RT. Hypertension Canada’s 2016 Canadian Hypertension Education Program guidelines for pharmacists: an update. Can Pharm J. 2016;149:337–44.

    Article  Google Scholar 

  27. Haines SL, DeHart RM, Hess KM, Marciniak MW, Mount JK, Phillips BB, et al. Report of the 2009-2010 Professional Affairs Committee: pharmacist integration in primary care and the role of academic pharmacy. Am J Pharm Educ. 2010;74:S5.

    PubMed  PubMed Central  Article  Google Scholar 

  28. Sabater-Hernández D, de la Sierra A, Bellver-Monzó O, Divisón JA, Gorostidi M, Perseguer-Torregosa Z, et al. Guía de actuación para el farmacéutico comunitario en pacientes con hipertensión arterial y riesgo cardiovascular. Documento de consenso (versión resumida). Hypertensión. 2011;28:169–81.

    Google Scholar 

  29. Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in adults. Executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71:1269–324.

    CAS  PubMed  Article  Google Scholar 

  30. Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. J Hypertens. 2018;36:1953–2041.

    CAS  PubMed  Article  Google Scholar 

  31. Omboni S, Tenti M. Telepharmacy for the management of cardiovascular patients in the community. Trends Cardiovasc Med 2018;pii: S1050-1738:30131-2.

  32. Abughosh S, Wang X, Serna O, Esse T, Mann A, Masilamani S, et al. A motivational interviewing intervention by pharmacy students to improve medication adherence. J Manag Care Spec Pharm. 2017;23:549–60.

    PubMed  Google Scholar 

  33. Milani RV, Lavie CJ, Bober RM, Milani AR, Ventura HO. Improving hypertension control and patient engagement using digital tools. Am J Med. 2017;130:14–20.

    PubMed  Article  Google Scholar 

  34. Magid DJ, Ho PM, Olson KL, Brand DW, Welch LK, Snow KE, et al. A multimodal blood pressure control intervention in 3 healthcare systems. Am J Manag Care. 2011;17:e96–103.

    PubMed  Google Scholar 

  35. Margolis KL, Asche SE, Bergdall AR, Dehmer SP, Groen SE, Kadrmas HM, et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA. 2013;310:46–56.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  36. Magid DJ, Olson KL, Billups SJ, Wagner NM, Lyons EE, Kroner BA. A pharmacist-led, American Heart Association Heart360 Web-enabled home blood pressure monitoring program. Circ Cardiovasc Qual Outcomes. 2013;6:157–63.

    PubMed  Article  Google Scholar 

  37. Green BB, Cook AJ, Ralston JD, Fishman PA, Catz SL, Carlson J, et al. Effectiveness of home blood pressure monitoring, web communication, and pharmacist care on hypertension control: a randomized controlled trial. JAMA. 2008;299:2857–67.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  38. Welch LK, Olson KL, Snow KE, Pointer L, Lambert-Kerzner A, Havranek EP, et al. Systolic blood pressure control after participation in a hypertension intervention study. Am J Manag Care. 2011;17:473–8.

    PubMed  Google Scholar 

  39. Margolis KL, Asche SE, Dehmer SP, Bergdall AR, Green BB, Sperl-Hillen JM, et al. Long-hypertension control and patient engagement using digital term outcomes of the effects of home blood pressure telemonitoring and pharmacist management on blood pressure among adults with uncontrolled hypertension. follow-up of a cluster randomized clinical trial. JAMA Netw Open. 2018;1:e181617.

    PubMed  PubMed Central  Article  Google Scholar 

  40. Green BB, Anderson ML, Ralston JD, Catz SL, Cook AJ. Blood pressure 1 year after completion of web-based pharmacist care. JAMA Intern Med. 2013;173:1250–2.

    PubMed  PubMed Central  Article  Google Scholar 

  41. Fishman PA, Cook AJ, Anderson ML, Ralston JD, Catz SL, Carrell D, et al. Improving BP control through electronic communications: an economic evaluation. Am J Manag Care. 2013;19:709–16.

    PubMed  PubMed Central  Google Scholar 

  42. Billups SJ, Moore LR, Olson KL, Magid DJ. Cost-effectiveness evaluation of a home blood pressure monitoring program. Am J Manag Care. 2014;20:e380–7.

  43. Dehmer SP, Maciosek MV, Trower NK, Asche SE, Bergdall AR, Nyboer RA, et al. Economic evaluation of the home blood pressure telemonitoring and pharmacist case management to control hypertension (Hyperlink) trial. J Am Coll Clin Pharm. 2018;1:21–30.

    PubMed  PubMed Central  Article  Google Scholar 

  44. Robins LS, Jackson JE, Green BB, Korngiebel D, Force RW, Baldwin LM. Barriers and facilitators to evidence-based blood pressure control in community practice. J Am Board Fam Med. 2013;26:539–57.

    PubMed  Article  Google Scholar 

  45. Kerby TJ, Asche SE, Maciosek MV, O’Connor PJ, Sperl-Hillen JM, Margolis KL. Adherence to blood pressure telemonitoring in a cluster-randomized clinical trial. J Clin Hypertens (Greenwich). 2012;14:668–74.

    Article  Google Scholar 

  46. Asche SE, O’Connor PJ, Dehmer SP, Green BB, Bergdall AR, Maciosek MV, et al. Patient characteristics associated with greater blood pressure control in a randomized trial of home blood pressure telemonitoring and pharmacist management. J Am Soc Hypertens. 2016;10:873–80.

    PubMed  PubMed Central  Article  Google Scholar 

Download references

Funding

No funds or grants were received for the preparation of this manuscript.

Author information

Authors and Affiliations

Authors

Contributions

SO devised the original idea of the work, made the search of the literature, and wrote the manuscript. MT and CC critically revised the manuscript. All authors met the ICMJE criteria for authorship for this manuscript, take responsibility for the integrity of the work as a whole, and have given final approval to the version to be published.

Corresponding author

Correspondence to Stefano Omboni.

Ethics declarations

Conflict of interest

SO is scientific consultant of Biotechmed Ltd, provider of telemedicine services. The remaining authors declare no conflicts of interest regarding the publication of this paper.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Omboni, S., Tenti, M. & Coronetti, C. Physician–pharmacist collaborative practice and telehealth may transform hypertension management. J Hum Hypertens 33, 177–187 (2019). https://doi.org/10.1038/s41371-018-0147-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41371-018-0147-x

Further reading

Search

Quick links